Ranitidine
Product Images NDC 0440-2300

2 FDA label images from Liberty Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 0440-2300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Liberty Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ran-150mg-otc-esophagus (Ranitidine 150 mg 60 Tabs For Apotex 1)

Ran-150mg-otc-esophagus (Ranitidine 150 mg 60 Tabs For Apotex 1)
An anatomical diagram showing the esophagus and stomach with a starburst marking the location where heartburn occurs, indicating acid reflux from the stomach into the esophagus.*
FDA Label Image

Image Label (Ranitidine 150 mg 60 Tabs For Apotex 2)

Image Label (Ranitidine 150 mg 60 Tabs For Apotex 2)
Ranitidine 150 mg tablet bottle label by Liberty Pharmaceuticals Inc. The label shows 60 tablets per bottle and specifies the active ingredient as ranitidine hydrochloride, film-coated, 150 mg per tablet. The label includes NDC 00440-2300-60, manufacturer Apotex Inc., Ontario, Canada, and packaging by Aidarex Pharmaceuticals LLC, Corona, CA. The label also contains spaces for doctor and patient information and dosing instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.